LICHEN SIMPLEX CHRONICUS
Clinical trials for LICHEN SIMPLEX CHRONICUS explained in plain language.
Never miss a new study
Get alerted when new LICHEN SIMPLEX CHRONICUS trials appear
Sign up with your email to follow new studies for LICHEN SIMPLEX CHRONICUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection could bring relief for debilitating skin itch
Symptom relief OngoingThis study is testing whether dupilumab injections can reduce severe itching in adults with lichen simplex chronicus, a skin condition causing intense itch and thickened skin patches. Participants receive either the active drug or placebo injections for 24 weeks, with researchers…
Matched conditions: LICHEN SIMPLEX CHRONICUS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC
-
New injection tested to stop debilitating skin itch
Symptom relief OngoingThis study is testing if dupilumab, given as an injection under the skin, can reduce severe, long-term itching and improve skin appearance in adults with lichen simplex chronicus (LSC). About 138 participants will receive either the study drug or a placebo injection for 24 weeks …
Matched conditions: LICHEN SIMPLEX CHRONICUS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC